Targeting of H19/cell adhesion molecules circuitry by GSK-J4 epidrug inhibits metastatic progression in prostate cancer.
Pecci V, Troisi F, Aiello A, De Martino S, Carlino A, Fiorentino V, Ripoli C, Rotili D, Pierconti F, Martini M, Porru M, Pinto F, Mai A, Bassi PF, Grassi C, Gaetano C, Pontecorvi A, Strigari L, Farsetti A, Nanni S.
Pecci V, et al. Among authors: troisi f.
Cancer Cell Int. 2024 Feb 5;24(1):56. doi: 10.1186/s12935-024-03231-6.
Cancer Cell Int. 2024.
PMID: 38317193
Free PMC article.